Literature DB >> 15138823

Differential effects of extracellular cesium on early afterdepolarizations in ventricular myocytes and arrhythmogenesis in isolated hearts of rats and guinea pigs.

C Ian Spencer1, John J Borg, Roland Z Kozlowski, James S K Sham.   

Abstract

CsCl has been shown to be arrhythmogenic in-vivo and to cause early afterdepolarizations (EADs) in isolated cardiac preparations, but the underlying electrophysiological mechanisms are ill-defined. To elucidate these actions further, the effects of extracellular solutions containing 3 mM CsCl and either 2 mM KCl (Cs2K solution) or 5 mM KCl (Cs5K solution) on membrane potential and ionic currents in rat and guinea-pig ventricular myocytes were compared. Cs2K solution rapidly and reversibly inhibited outward I(K1), and reduced other K(+) currents by about 20%. Current-clamped myocytes were rapidly hyperpolarized by this solution and action potentials were prolonged, but EADs were not observed. In contrast, EADs were triggered by E-4031, H(2)O(2), and the pyrethroid tefluthrin. Membrane-potential changes reversed after replacing Cs2K with Cs5K solution, with the recovery of 50% of outward I(K1). These results suggest that Cs2K solution inhibited I(K1) and caused a late prolongation of the action-potential duration, but the affected membrane potentials were too negative to elicit EAD mechanisms. In isolated hearts perfused with modified Tyrode's, Cs2K, and Cs5K solutions, bradycardia and arrhythmias were evoked by both CsCl-containing solutions. A comparison of such results with the effects of these solutions on myocytes suggests that I(K1) inhibition and EADs in ventricular myocytes are unlikely to be involved in arrhythmogenesis under our conditions.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15138823     DOI: 10.1007/s00424-004-1281-6

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  45 in total

Review 1.  Triggered activity in the heart: cellular mechanisms of early after-depolarizations.

Authors:  C T January; V Chau; J C Makielski
Journal:  Eur Heart J       Date:  1991-12       Impact factor: 29.983

Review 2.  Cardiac channelopathies.

Authors:  Eduardo Marbán
Journal:  Nature       Date:  2002-01-10       Impact factor: 49.962

3.  Cardiac Purkinje fibers: cesium as a tool to block inward rectifying potassium currents.

Authors:  G Isenberg
Journal:  Pflugers Arch       Date:  1976-09-30       Impact factor: 3.657

4.  Arrhythmogenesis and contractile dysfunction in heart failure: Roles of sodium-calcium exchange, inward rectifier potassium current, and residual beta-adrenergic responsiveness.

Authors:  S M Pogwizd; K Schlotthauer; L Li; W Yuan; D M Bers
Journal:  Circ Res       Date:  2001-06-08       Impact factor: 17.367

5.  Cardiovascular and metabolic effects of caesium chloride injection in dogs--limitations as a model for the long QT syndrome.

Authors:  M Nayebpour; B C Solymoss; S Nattel
Journal:  Cardiovasc Res       Date:  1989-09       Impact factor: 10.787

6.  K+ current inhibition by amphiphilic fatty acid metabolites in rat ventricular myocytes.

Authors:  Z Xu; G J Rozanski
Journal:  Am J Physiol       Date:  1998-12

7.  Alterations in electrical and contractile behavior of isolated cardiomyocytes by hydrogen peroxide: possible ionic mechanisms.

Authors:  A Beresewicz; M Horackova
Journal:  J Mol Cell Cardiol       Date:  1991-08       Impact factor: 5.000

8.  Electrophysiological effects of cesium and tetraethylammonium in canine cardiac Purkinje fibers.

Authors:  A A Kinnaird; R Y Man
Journal:  J Pharmacol Exp Ther       Date:  1991-09       Impact factor: 4.030

Review 9.  Inward rectification and implications for cardiac excitability.

Authors:  C G Nichols; E N Makhina; W L Pearson; Q Sha; A N Lopatin
Journal:  Circ Res       Date:  1996-01       Impact factor: 17.367

10.  Voltage-dependent block of cardiac inward-rectifying potassium current by monovalent cations.

Authors:  R D Harvey; R E Ten Eick
Journal:  J Gen Physiol       Date:  1989-08       Impact factor: 4.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.